Detection of Early Response to Temozolomide Treatment in Brain Tumors Using Hyperpolarized (13)C MR Metabolic Imaging

PURPOSE: To demonstrate the feasibility of using DNP hyperpolarized [1-(13)C]-pyruvate to measure early response to temozolomide (TMZ) therapy using an orthotopic human glioblastoma xenograft model. MATERIALS AND METHODS: Twenty athymic rats with intracranial implantation of human glioblastoma cells...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Magn Reson Imaging
Päätekijät: Park, Ilwoo, Bok, Robert, Ozawa, Tomoko, Phillips, Joanna J., James, C. David, Vigneron, Daniel B., Ronen, Sabrina M., Nelson, Sarah J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4983457/
https://ncbi.nlm.nih.gov/pubmed/21590996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmri.22563
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia